Phenotypic Transition From Danon Disease to Arrhythmogenic Cardiomyopathy
- 1Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil
- 2Hospital Israelita Albert Einstein, Sao Paulo, Brazil
Abstract
Background: Pathogenic variants in lysosome-associated membrane protein 2 (LAMP2) gene cause X-linked Danon disease, associated with hypertrophic cardiomyopathy. Arrhythmogenic cardiomyopathy is characterized by myocardial fibrofatty replacement and ventricular arrhythmias.
Case Summary: A 30-year-old woman presented with a hypertrophic phenotype and a short PR interval. At 40 years of age, she developed progressive diffuse low QRS complex voltages and recurrent ventricular arrhythmias. Cardiac magnetic resonance showed extensive ring-like late gadolinium enhancement and biventricular systolic dysfunction, consistent with biventricular arrhythmogenic cardiomyopathy. Genetic testing identified a pathogenic LAMP2 variant (LAMP2:c.928G>A; p.Val310Ile) associated with Danon disease. Despite optimized medical therapy, she progressed to advanced heart failure requiring heart transplantation. The explanted heart demonstrated severe fibrofatty myocardial replacement, with thinning of the right ventricular wall and vacuolated cardiomyocyte, which were strongly stained by periodic acid–Schiff.
Discussion: Danon disease is characterized by myocardial hypertrophy, but not by fibrofatty replacement, which is a hallmark of arrhythmogenic cardiomyopathy. This case demonstrates a rare phenotypic evolution in LAMP2 cardiomyopathy.
Related
- Disease Stage and Efficacy Interpretation in Gene Therapy for Arrhythmogenic Cardiomyopathy
- Elimination of Epicardial Late Potentials by Endocardial Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy
- Incremental prognostic value of hepatic tissue alterations derived from cardiac magnetic resonance imaging for arrhythmogenic right ventricular cardiomyopathy: a case-control study
- Risk Stratification and Outcomes of Right Atrial Phasic Function in Arrhythmogenic Right Ventricular Cardiomyopathy: A Cardiac Magnetic Resonance Study
- Clinical relevance of lead-induced tricuspid regurgitation after transvenous implantable cardioverter-defibrillator implantation in arrhythmogenic cardiomyopathy
BibTeX
@article{olivetti2026phenotypic,
title = {{Phenotypic Transition From Danon Disease to Arrhythmogenic Cardiomyopathy}},
author = {Natália Quintella Sangiorgi Olivetti and Giovana Pereira Belitardo and Felipe Cerqueira Matheus and Deborah Belfort and Luiz Alberto Benvenuti and Luciana Sacilotto and Edimar Bocchi and Giovanna Napolitano and José Eduardo Krieger and Silvia Ayub},
journal = {JACC Case Reports},
year = {2026},
month = sep,
doi = {10.1016/j.jaccas.2026.110385},
url = {https://doi.org/10.1016/j.jaccas.2026.110385},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Phenotypic Transition From Danon Disease to Arrhythmogenic Cardiomyopathy
AU - Natália Quintella Sangiorgi Olivetti
AU - Giovana Pereira Belitardo
AU - Felipe Cerqueira Matheus
AU - Deborah Belfort
AU - Luiz Alberto Benvenuti
AU - Luciana Sacilotto
AU - Edimar Bocchi
AU - Giovanna Napolitano
AU - José Eduardo Krieger
AU - Silvia Ayub
PY - 2026
DA - 2026/09/23
JO - JACC Case Reports
DO - 10.1016/j.jaccas.2026.110385
UR - https://doi.org/10.1016/j.jaccas.2026.110385
AB - Background: Pathogenic variants in lysosome-associated membrane protein 2 (LAMP2) gene cause X-linked Danon disease, associated with hypertrophic cardiomyopathy. Arrhythmogenic cardiomyopathy is characterized by myocardial fibrofatty replacement and ventricular arrhythmias. Case Summary: A 30-year-old woman presented with a hypertrophic phenotype and a short PR interval. At 40 years of age, she developed progressive diffuse low QRS complex voltages and recurrent ventricular arrhythmias. Cardiac magnetic resonance showed extensive ring-like late gadolinium enhancement and biventricular systolic dysfunction, consistent with biventricular arrhythmogenic cardiomyopathy. Genetic testing identified a pathogenic LAMP2 variant (LAMP2:c.928G>A; p.Val310Ile) associated with Danon disease. Despite optimized medical therapy, she progressed to advanced heart failure requiring heart transplantation. The explanted heart demonstrated severe fibrofatty myocardial replacement, with thinning of the right ventricular wall and vacuolated cardiomyocyte, which were strongly stained by periodic acid–Schiff. Discussion: Danon disease is characterized by myocardial hypertrophy, but not by fibrofatty replacement, which is a hallmark of arrhythmogenic cardiomyopathy. This case demonstrates a rare phenotypic evolution in LAMP2 cardiomyopathy.
SN - 2666-0849
ER -